Viral proteomics: The emerging cutting-edge of virus research

Science China Life Sciences

Volumn 54, Issue 6, 2011, Pages 502-512

  Zhou, Sheng Tao ^a,b   Liu, Rui ^b   Zhao, Xia ^a   Huang, Can Hua ^b   Wei, Yu Quan ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

proteomics; virion proteomics; virus; virus host interaction

Indexed keywords

PROTEOME; VIRUS PROTEIN;

ANIMAL; CHEMISTRY; HOST PATHOGEN INTERACTION; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; METHODOLOGY; PROTEOMICS; REVIEW; RNA INTERFERENCE; RNA VIRUS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRION; VIRUS; VIRUS INFECTION;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; RNA INTERFERENCE; RNA VIRUSES; VIRAL PROTEINS; VIRION; VIRUS DISEASES; VIRUSES;

EID: 79959579484     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4177-7     Document Type: Review

References (59)

1. Karen L M, Lori F. Viral proteomics. Microbiol Mol Biol Rev, 2007, 71: 398-411.
2. Yuan K, Lei Y L, Huang C. Application of chemistry-based functional proteomics to screening for novel drug targets. Comb Chem High Throughput Screen, 2010, 13: 414-421.
3. Liu R, Bai S J, Li Z J, et al. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signalling pathway. Mol Cell Proteomics, 2009, 8: 70-85.
4. Miklos G L, Maleszka R. Protein functions and biological contexts. Proteomics, 2001: 169-178.
5. Nair K S, Asmann Y W, Short K R, et al. Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol Endocrinol Metab, 2004, 286: 863-874.
6. Fields B N, Howley P M. Fundamental virology. In: Principles of Virus Structure, 3rd ed. Philadelphia: Lippincott, Williams & Willkins, 1996. 59-100.
7. Kalkkinen N, Soderlund H, Kaariainen L. Analysis of semliki-forest-virus structural proteins to illustrate polyprotein processing of alpha viruses. Eur J Biochem, 1980, 108: 31-37.
8. Chelius D, Shieh C H, Lehmberg E, et al. Analysis of the adenovirus type 5 proteome by liquid chromatography and tandem mass spectrometry methods. J Proteome Res, 2002, 1: 501-513.
9. Davison A J, Davison M D. Identification of structural proteins of channel catfish virus by mass spectrometry. Virology, 1995, 206: 1035-1043.
10. Resch W G, Moore R J, Lipton M S, et al. Protein composition of the vaccinia virus mature virion. Virology, 2007, 358: 233-247.
11. Chung C S, Ho M Y, Huang C Y, et al. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J Virol, 2006, 80: 2127-2140.
12. Yoder J D, Gagnier C R, Vemulapalli S, et al. Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins. Virol J, 2006, 3: 10-26.
13. Baldick C J, Shenk T. Proteins associated with purified human cytomegalovirus particles. J Virol, 1996, 70: 6097-6105.
14. Kattenhorn L M, Wagner M, Lomsadze A, et al. Identification of proteins associated with murine cytomegalovirus virions. J Virol, 2004, 78: 11187-11197.
15. Johannsen E, Chase M R, Weicksel S, et al. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA, 2004, 101: 16286-16291.
16. Zhu F X, Wu L J, Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol, 2005, 79: 800-811.
17. O'Connor C M, Kedes D H. Mass spectrometric analyses of purified Rhesus monkey rhadinovirus reveal 33 virion-associated proteins. J Virol, 2006, 80: 1574-1583.
18. Huang C H, Lin Q S, Xu X, et al. Proteomic analysis of shrimp white spot syndrome viral proteins and characterization of a novel envelope protein VP466. Mol Cell Proteomics, 2002, 1: 223-231.
19. Li Z, Chen J, Wu J L, et al. Shotgun identification of the structural proteome of shrimp white spot syndrome virus and iTRAQ differentiation of envelope and nucleocapsid subproteomes. Mol Cell Proteomics, 2007, 6: 1609-1620.
20. Zeng R, Jiang X S, Zhou H, et al. Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. J Proteome Res, 2004, 3: 549-555.
21. Saphire A C, Bark S J. Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res, 2006, 5: 530-538.
22. Chertova E, Coren L V, Roser J D, et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol, 2006, 80: 9039-9052.
23. Bortz E, Whitelegge J P, Jia Q M, et al. Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol, 2003, 77: 13425-13432.
24. Varnum S M, Monroe M E, Smith P, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol, 2004, 78: 10960-10966.
25. Rozen R, Li Y, Yuan Y. Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J Virol, 2008, 82: 4742-4750.
26. Bartel P L, Roecklein J A, SenGupta D, et al. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol, 2005, 79: 4952-4964.
27. Vliet K V, Zhang L L, Villa N Y, et al. Poxvirus proteomics and virushost protein interactions. Microbiol Mol Biol Rev, 2009, 73: 730-749.
28. Oliver K B, Russel J D, Anthony L C. New insights into viral structure and virus-cell interactions through proteomics. Expert Rev Proteomics, 2005, 2: 577-588.
29. Bortz E, Whitelegge J P, Jia Q, et al. Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol, 2003, 77: 13425-13432.
30. Ying W T, Zhang Y J, Peng W M, et al. Proteomic analysis on structural proteins of severe acute respiratory syndrome coronavirus. Proteomics, 2004, 4: 492-504.
31. Savalia D, Westblade L F, Goel M, et al. Genomic and proteomic Analysis of phiEco32, a novel Esacherichia coli bacteriophage. J Mol Biol, 2008, 377: 774-789.
32. Robert M D, Martin N L, Kropinski A M. The genome and proteome of coliphage T1. Virology, 2004, 318: 245-266.
33. Naryshkina T, Liu J, Florens L, et al. Thermus thermophilus bacteriophage phiYS40 genome and proteomic characterization of virions. J Mol Biol, 2006, 364: 667-677.
34. Beijerinck M J. Concerning a contagium vivum fluidum as cause of the spot disease of tobacco leaves. Verhandelingen der Koninkyke akademie Wettenschapppen te Amsterdam, 1898, 65: 3-21.
35. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature, 1989, 340: 245-246.
36. Fields S. Interactive learning: Lessons from two hybrids over two decades. Proteomics, 2009, 9: 5209-5213.
37. Mendez-Rios J, Uetz P. Global approaches to study protein-protein interactions among viruses and hosts. Future Microbiol, 2010, 5: 289-301.
38. Bartel P L, SenGupta D, Fields S. A protein linkage map of Escherichia coli bacteriophage T7. Nat Genet, 1996, 12: 72-77.
39. McCraith S, Moss B, Fields S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci USA, 2000, 97: 4879-4884.
40. Dziembowski A, Ventura A P, Rutz B, et al. Proteomic analysis identifies a new complex required for nuclear pre-mRNA retention and splicing. EMBO J, 2004, 23: 4847-4856.
41. Jorba N, Torreira E, Gastaminza P, et al. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics, 2008, 8: 2077-2088.
42. Mayer D, Martinez-Sobrido L, Ghanem A, et al. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res, 2007, 6: 672-682.
43. Molina-Jiménez F, Murata M, Martín-Vílchez S, et al. Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation. Hepatol, 2010, 51: 777-787.
44. Cristea I M, Carroll J N, Rout M P, et al. Tracking and elucidating alphavirus-host protein interactions. J Biol Chem, 2006, 281: 30269-30278.
45. Hirsch A J. The use of RNAi-based screens to identify host proteins involved in viral replication. Future Microbiol, 2010, 5: 303-311.
46. Brass A L, Dykxhoor D M, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomics screen. Science, 2008, 319: 921-926.
47. Konig R, Zhou Y Y, Elleder D, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell, 2008, 135: 49-60.
48. Tong A P, Gou L T, Lau Q C, et al. Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein. J Proteome Res, 2009, 8: 1037-1046.
49. Toda T, Sugimoto M, Omori A, et al. Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastiod cell lines before and after immortalization. Electrophoresis, 2000, 21: 1814-1822.
50. Coiras M, Camafeita E, Urena T, et al. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics, 2006, 6: S63-S73.
51. Chen X, Yu Y B, Xue Y, et al. Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev Proteomics, 2007, 4: 25-37.
52. Mannova P, Wang H, Deng B, et al. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics, 2006, 5: 2319-2325.
53. Zhang L, Zhang X E, Lin F S, et al. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication. J Virol, 2010, 84: 6050-6059.
54. Booy A T, Ohlund L B, Hardie D B, et al. Application of isotope coded affinity tag (ICAT) analysis for the identification of differentially expressed proteins following infection of atlantic salmon (Salmo salar) with infectious hematopoietic necrosis virus (IHNV) or Renibacterium salmoninarum (BKD). J Proteome Res, 2005, 4: 325-334.
55. Go E P, Wikoff W R, Shen Z, et al. Mass spectrometry reveals specific and global molecular transformations during viral infection. J Proteome Res, 2006, 5: 2405-2416.
56. Jiang X S, Tang L Y, Dai J, et al. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approach. Mol Cell Proteomics, 2005, 4: 902-913.
57. Chen L M, Lin Q S, Lim T K, et al. iTRAQ analysis of Singapore grouper iridovirus infection in a grouper embryonic cell line. J General Virol, 2008, 89: 2869-2876.
58. Diamond D L, Jacobs J M, Paeper B, et al. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatol, 2007, 46: 649-657.
59. Chan E Y, Qian W J, Diamond D L, et al. Quantitative analysis of HIV-1 infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol, 2007, 81: 7571-7583.